Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Skin Neoplasms × Tacrolimus × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Myelodysplastic Syndromes 17 Lymphoma 12 Leukemia, Myeloid, Acute 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Lymphoma, Non-Hodgkin 11 Lymphoma, Follicular 11 Leukemia 11 Multiple Myeloma 10 Leukemia, Lymphocytic, Chronic, B-Cell 10 Hodgkin Disease 10 Lymphoma, Mantle-Cell 8 Lymphoma, Large B-Cell, Diffuse 7 Lymphoma, B-Cell, Marginal Zone 7 Leukemia, Myelomonocytic, Chronic 6 Leukemia, Myeloid, Accelerated Phase 6 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6 Waldenstrom Macroglobulinemia 5 Primary Myelofibrosis 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5 Neoplasms, Plasma Cell 5 Myeloproliferative Disorders 5 Leukemia, Myeloid, Chronic-Phase 5 Hematologic Neoplasms 5 Graft vs Host Disease 5 Burkitt Lymphoma 5 Blast Crisis 5 Lymphoma, Large-Cell, Anaplastic 4 Congenital Abnormalities 4 Sezary Syndrome 3 Myelodysplastic-Myeloproliferative Diseases 3

Interventions

Cyclophosphamide 11 fludarabine 8 aldesleukin 8 fludarabine phosphate 6 pembrolizumab 5 Nivolumab 4 Ipilimumab 4 Interleukin-2 4 dabrafenib 2 Vemurafenib 2 Biopsy 2 Aminolevulinic Acid 2 varlilumab 1 trametinib 1 tilsotolimod 1 spartalizumab 1 sotigalimab 1 sonidegib 1 smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic 1 glembatumumab vedotin 1 eprenetapopt 1 encorafenib 1 cemiplimab 1 cabozantinib 1 binimetinib 1 bempegaldesleukin 1 abobotulinumtoxinA 1 X-Rays 1 Tranexamic Acid 1 Tacrolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00866684 2025-03-14

PROSKIN

Charite University, Berlin, Germany

Phase 4 Terminated

44 enrolled 7 charts

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡